臨床研究等提出・公開システム

Date of registration	Mar. 12, 2025
Last modified on	Mar. 12, 2025
Trial ID	jRCT1020240064

Scientific Title	Verification Study of the New (Awareness-Based) Health Screening Program in Companies
Public Title	Verification Study of the New (Awareness-Based) Health Screening Program in Companies

Contact for Scientific Queries	Name	Mikami Tasuya
	Affiliation	Hirosaki University Graduate School of Medicine
	Address	5 Zaifu-cho, Hirosaki City, Aomori, Japan
	Telephone	+81-172-39-5511
	E-mail	tmika@hirosaki-u.ac.jp
Contact for Public Queries	Name	Yokoyama Shintaro
	Affiliation	Hirosaki University Graduate School of Medicine
	Address	5 Zaifu-cho, Hirosaki City, Aomori, Japan
	Telephone	+81-172-39-5511
	E-mail	shintaro-y@hirosaki-u.ac.jp

Recruitment status	Not Recruiting

Anticipated date of first enrollment		May. 07, 2019
Actual date of first enrollment		May. 07, 2019
Target sample size		500
Study Type		Interventional
Study Design	allocation	non-randomized controlled trial
	masking	open(masking not used)
	control	no treatment control/standard of care control
	assignment	parallel assignment
	purpose	prevention purpose
Key inclusion & exclusion criteria	Inclusion Criteria	Employees aged 20 and older working at companies in Aomori Prefecture. Individuals who fully understand the purpose and details of this study and have provided consent to participate. Individuals who have undergone a company-sponsored health checkup or an external health examination. Individuals willing to utilize their health screening results and participate in the health education and follow-up program.
	Exclusion Criteria	Subjects of Specific Health Guidance
	Age Minimum	20age old over
	Age Maximum	No limit
	Gender	Both
Health Condition(s) or Problem(s) Studied		Prevention of Lifestyle-Related Disease
Intervention(s)		Participants in the intervention group will receive the implementation of the "New (Awareness-Based) Health Screening Program" and health education. This includes immediate feedback from a comprehensive health screening covering metabolic syndrome, locomotive syndrome, oral health, and mental health, as well as the continuous provision of health-related information.
Primary Outcome(s)		Improvement in health literacy, behavioral change, enhancement of health indicators related to metabolic syndrome, locomotive syndrome, oral health, and mental health.
Secondary Outcome(s)		Reduction of healthcare costs

Primary Sponsor	Hirosaki University

Secondary Sponsor

Source of Monetary Support	Center of Innovation (COI) Program
Secondary Sponsor

Name of Certified Review Board	Committee of Medical Ethics of Hirosaki University Graduate School of Medicine
Address	5 Zaifucho, Hirosaki, Aomori, Aomori, Aomori
Telephone	+81-172-33-5111
E-Mail	rinri@hirosaki-u.ac.jp
Date of approval	April. 01, 2024

Countries of Recruitment（Except Japan）	none